Back to User profile » Dr Shanglin Cai
Papers published by Dr Shanglin Cai:
Original Research
High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients
Dai Y, Pan B, Zhao J, Cai S, Li J, Zou B
Journal of Hepatocellular Carcinoma 2026, 13:600072
Published Date: 14 April 2026
Original Research
Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α
Zhao J, Lin E, Cai C, Zhang M, Li D, Cai S, Zeng G, Yin Z, Wang B, Li P, Hong X, Chen J, Zou B, Li J
Drug Design, Development and Therapy 2022, 16:3197-3213
Published Date: 19 September 2022